Presentation Information
[O12-5]Comparison of endoscopic and histological efficacies among patients with ulcerative colitis treated with infliximab, vedolizumab, and ustekinumab as first-line biologics: A multicenter randomized control study
*Makoto Naganuma1, Hisashi Shiga2, Norimasa Fukata1, Tadakazu Hisamatsu3 (1.Third Department of Internal Medicine, Kansai Medical University, 2.Division of Gastroenterology, Tohoku University Graduate School of Medicine, 3.Department of Gastroenterology and Hepatology, Kyorin University School of Medicine)
Password required to view
The password for viewing abstracts is printed on your name card.